Close Menu

Former Executive of Amgen, Immunex Joins Seattle office of Darby and Darby

Michael Kirschner has joined the Seattle office of Darby and Darby as a principal in the law firm’s chemical & life sciences, and litigation & dispute resolution practice groups, with a specialty in biotechnology.

Kirschner joins Darby & Darby from Hillis Clark Martin & Peterson. He has also served as a vice president of Immunex, and as head of Amgen's Seattle law office after the company acquired Immunex.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.